Reuters logo
10 months ago
BRIEF-EMA recommends conditional approval of Abbvie leukemia drug
October 14, 2016 / 11:18 AM / 10 months ago

BRIEF-EMA recommends conditional approval of Abbvie leukemia drug

Oct 14 (Reuters) - European Medicines Agency(EMA):

* EU Medicines Agency recommendations for October 2016

* EU Medicines Agency recommends approval of Abbvie Inc'S Venetoclax/Venclexta to treat leukaemia

* EU Medicines Agency recommends conditional marketing approval of Intercept Pharmaceuticals Inc'S Ocaliva to treat primary biliary cirrhosis Link to source: (bit.ly/2dYKT7R) (Bengaluru Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below